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CHARACTERIZATION OF UHRFl EXPRESSION IN HUMAN INDUCED 
PLURIPOTENT STEM CELLS AND IN UHRFl CONDITIONAL KNOCKOUT 
MODELS 
ANAL DESAI 
Boston University School ofMedicine, 2012 
Major Professor: Karen Symes, Ph.D., Associate Professor, Department of Biochemistry. 
ABSTRACT 
UHRFl (ubiquitin-like protein, containing PHD and RING finger domains 1) is 
essential in epigenetic modification and cell cycle progression. In vivo knockdown of 
UHRF 1 is lethal and embryogenesis does not progress to produce viable knockout 
models. In this study, Cre recombinase adenovirus is used to generate an in vitro 
knockdown of Uhrfl in Mouse Embryo Fibroblasts. The study also proposes the use of 
Albumin-Cre mouse model and Cre-lox technology to make conditional Uhrfl 
knockdown in the liver. These models will prove to be essential in further experiments to 
understand the precise role of UHRF1 and its homologs. Unlike in non-mammals, a 
number ofUHRF1 homologs have been identified in mammals but their exact function is 
disputed. This study measures the mRNA expression of UHRF1 and UHRF2 in human 
induced pluripotent stem cells as they differentiate into hepatocytes and show that mRNA 
expression of UHRF2 is significantly higher in differentiated cells as compared to the 
expression of UHRF 1. There have been studies that show UHRF 1 expression at various 
v 
cell cycle phases, but there is little known about the regulation of UHRFl itself. To 
further understand the relation between DNA methylation and UHRFl expression, this 
study shows that hypomethylation of DNA with methylation inhibitor, 5-Azacytidine, 
induces an increase in UHRFl expression, suggesting that UHRFl not only regulates the 
gene expression by DNA methylation but may also play a role in self-regulating its own 
expressiOn. 
Note: The paper uses the following convention; UHRFl: humans, Uhrfl (rodent), uhrfl 
(non-mammalian). Elsewhere, UHRFl is used as default for nucleic acid and protein. 
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Chronic liver disease is currently the 1th most common cause of death in United 
State. It has the fastest growing incidence of any cancer in US and Western Europe and is 
the fifth most common cancer worldwide and the third leading cause of cancer related 
death. Prognosis is dire among patients with hepatocellular carcinoma and currently 
resection or transplantation is the only curative therapies. Identifying the genes that 
contribute to deregulate hepatocyte proliferation can aid in the design of effective 
therapies against hepatocellular carcinoma. UHRF1 (ubiquitin-like protein, containing 
PHD and RING finger domains 1) has been identified as an important role in cell cycle 
regulation and hepatocyte proliferation. 
Structure of UHRFl 
UHRF, also known as NP95 (nuclear protein 95) in mouse and ICBP90 (inverted 
CCAAT box binding protein 90 but hereafter referred to as UHRF1) in human, is a multi-
domain protein which plays an important role in epigenetic regulation through chromatin 
modification, DNA methylation, and histone modification (Chu et al., 2012). Moreover, 
it also plays a critical role in cell cycle regulation, cell apoptosis, and carcinogenesis. At 
present, UHRF1 is speculated to be compromised of five distinct domains from N to C 
terminus: an ubiquitin-like domain (UBL), a tandem tudor domain, a plant homeodomain 
(PHD), a SET and RING associated (SRA) domain, and a really interesting new gene 
(RING) domain (Fig. 1) (Hashimoto et al., 2009). 
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Structure-Function Relationships 
The PHD domain of UHRF1 interacts with methylated histones and also with the 
principal methyltranferase that maintains DNA methylation, DNMT-1 (DNA 
Methyltransferase-1 ). The tandem Tudor domain binds trimethylated histone H3 lysine 9 
(H3K9me3). The SRA domain has been shown to interact with hemimethylated DNA 
(Avvakumov et al. , 2008) and with DNMT1 , DNMT3a, DNMT3b and histone 
deacetylase 1 (HDAC1) (Chu et al. , 2012). The RING domain has an E3-ubiquiting-
ligase activity in addition to playing a role in recruiting histone methyltransferase G9a in 
conjunction with the SRA domain. The roles played by individual domains, strongly 




Figure 1. Structure of the UHRFl Domains. 
(A) The location and sequence of the known domains on the UHRFI gene. An N-terminal ubiquitin-like 
domain (UBL) is followed by a tandem Tudor domain, a plant homeodomain (PHD), a SET and RING 
associated (SRA) domain and a C-terminal really interesting new gene (RING) domain. (B) Protein crystal 
structure of the five domains. (Figure amended from Hashimoto et a!., 2009. Downloaded from 
www .landesbioscience.com) 
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UHRFl Plays a Role in Epigenetic Regulation 
Epigenetic regulation refers to heritable changes in gene expression that are not due 
to the changes in the DNA sequence but are a result of chemical modification of bases. 
During post-replication phase, a methyl (CH3) group is added to the fifth carbon of 
certain specific cytosine bases by enzymes known as DNMTs (DNA Methyl 
Transferases). DNA methylation in mammals primarily occurs at CG-rich promoter 
regions, called 'CpG islands', where "p" denotes the phosphate group in the 
polynucleotide backbone. DNMTl has been shown to have a higher affinity for 
hemimethylated DNA compared to symmetrically methylated DNA, but this property is 
not sufficient to maintain the accuracy of DNA methylation mechanism in cells (Ooi et 
al., 2008). The process of maintenance has recently been revealed through the 
determination of the crystal structure of the SRA domain of UHRF 1 complexed to DNA. 
This structure reveals an arrangement of a-helices and P-barrels that form a 'binding 
pocket'. The specialized pocket binds 5-methylcytosine and flips it out of the double 
helix. The organization of amino acids in the pocket makes it highly specific to capture 
methylated cytosines and through UHRFl interaction with DNMTl, it makes 
hemimethylated DNA quite accessible for DNMTl to maintain its efficacy in DNA 
methylation (Ooi et al., 2008). Methylation of DNA prevents the transcription of genes 
that are not necessary a given phase or stage of the cell. Similarly to DNA, methylation of 
histones can increase their affinity for DNA, thereby preventing transcription factors 
from accessing DNA. Histones are proteins that form an interior core around which DNA 
is wrapped. An octamer ofhistones, containing a pair ofH2A, H2B, H3 , and H4 histones, 
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together with ~200bp DNA is called a 'nucleosome'. A nucleosome forms the first level 
of organization for a chromosome. Since the DNA is densely packed around histones, it 
needs to be unwound before it can be replicated or transcribed. Modifications on theN-
terminal tails of histones through methylation at certain lysine (K) and arginine (R) 
residues regulate this process (Rajakumara et al., 2011). The PHD domain of UHRF1 
recognizes unmethylated H3 and H4 tails and decreases the binding affinity towards 
methylated residues on H3 (Ooi et al., 2008). The PHD domain has two zinc fingers and 
anN-terminal motif, the amino acid sequence of which binds to unmodified H3R2. On 
the contrary, the tandem Tudor domain of UHRF1 has a structure that has increased 
preference for trimethylated (H3K9me3) peptide (Rottach et al., 201 0). Histone 
methylation provides a binding surface for chromatin modifying enzymes, which regulate 
chromatin condensation and nucleosome modification and maintain regions of chromatin 
that can be actively accessed for transcription and gene expression. Although the exact 
mechanism is unknown, it is clear that the PHD and Tudor domains of UHRF 1 regulate 
epigenetic modification of genes via histone methylation. 
Another biochemical process for regulation of histone and thus chromatin structure 
is through acetylation (Unoki et al., 2004). During chromosome replication inS phase, an 
acetyl group from Acetyl Coenzyme A is transferred on to the lysine residue on N-
terminal tail of core histones by histone acetyltransferases (HATs). Acetylation removes 
the positive charge from the lysines decreasing their affinity to bind to the negatively 
charged phosphate backbone of DNA (Clayton et al., 2006). A decrease in binding 
affinity causes DNA to relax, allowing factors to bind to promoters and activate gene 
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transcription. The activation can be reversed by histone deacetylases (HDACs) which 
transfer the acetyl group back to coenzyme A. Increased histone acetylation has been 
linked to domains containing active genes (Sealy et al. , 1978), suggesting its role in 
epigenetic regulation of genes. The SRA domain of UHRF1 interacts directly with 
HDAC1 (Unoki et al. , 2004). Though the mechanism of action is not conclusively 
proven, it can be speculated that by interacting with HDAC 1, UHRF 1 can inhibit 
transcription of anti-oncogenic genes such as tumor suppressor genes. 
UHRF 1 has also been shown to play a role in the regulation of peri centric 
heterochromatin (PH). PH regions in chromosomes continuously go through a dynamic 
process of reorganization and form localized aggregates of permanently silenced 
chromosomal regions called ' Chromocenters ' (Hochstrasser et al. , 1987). The structure of 
chromocenters responds to external stimuli and this change is responsible for alterations 
in gene activation, cell proliferation and differentiation (Papait et al., 2008). During S 
phase, PH regions need to be replicated and reformed in daughter cells. The PHD domain 
of Uhrfl is involved both in the replication of PH due to its interaction with hi stones, and 
the formation of new PH regions in daughter cells during post-replication phase (Papait et 
al., 2008). In sum, studies have shown the involvement of all domains of UHRFlin 
DNA, histone, or chromatin modification, reinforcing the importance of the protein in 
epigenetic regulation of genes. 
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Absence of UHRFl Causes Cell Cycle Arrest & Apoptosis 
Multiple lines of evidence implicate UHRF1 in the control of the cell cycle. A 
eukaryotic cell division cycle is composed of an ordered set of events that results in the 
generation of two copies of the preexisting cell. The cell cycle is partitioned into distinct 
phases, each regulated by a series of proteins. DNA replication occurs during the S phase 
and cell division occurs in the M phase. Both of these are separated by "Gap" phases 
during which the cell grows. Once the cell completes the M phase, it is suspended in GO 
phase, until it is triggered to enter the G 1 phase by external factors. Interaction of 
checkpoint proteins such as Cyclin dependent kinases (CDKs) and cyclins regulate the 
cell cycle through various phases. In case of DNA damage or DNA replication blocks, 
checkpoint proteins arrest the cell cycle and induce repair or apoptosis. The arrest allows 
the cell to monitor the physical capability of a cell to continue functioning properly. The 
failure to do so compromises the cells ability to rectify mistakes in DNA replication, 
producing cells with damaged DNA and uncontrolled proliferation and leading to 
carcinogenesis. The transcription and translation levels of Uhrfl have been shown to vary 
through different points in a cell cycle of a normal cell, while the levels remain more or 
less unchanged in cancerous cells (Chu et al. , 2012). 
Murine Uhrfl (NP95) knockdown cells were also found to have increased 
sensitivity to genotoxic agents such as x-rays, UV light, N-methyl-N"-nitro-N-
nitrosoguanidine (MNNG), and hydroxyurea as compared to normal wild type (Np95+1+) 
and heterozygous (Np95 +!-). When Uhrfl was re-introduced into the knockdown cells 
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this sensitivity was lost, suggesting a role for UHRF1 in the repair of DNA damage 
(Muto et al., 2002). Studies from our lab show that in cancer cells, UHRF1 accumulates 
at sites of DNA damage and co-localizes with other proteins such as Histone y-H2AX, 
suggesting that the cell cycle block in UHRF 1-depleted cells is due to an important role 
in damage repair (Tien et al., 2011). As the fidelity of DNA is highly dependent on 
UHRF1, both due to its direct interaction with DNA methylation and indirectly through 
interaction with proteins such as DNMT1 and HDAC 1, loss of the protein is expected to 
lead to genomic instability, induce a cell cycle arrest or lead to death of cells with 
genomic defects. Although studies have been inconsistent with the exact phase where 
UHRF1 acts in a cell cycle with some depicting cell arrest in G 1 phase, while studies 
from our lab suggesting G2/M phase (Tien et al., 2011 ), there is little doubt that UHRF 1 
is a necessary protein for cell cycle progression. 
For cells with loss of UHRF1 where genomic stability may be compromised, cell 
apoptosis or 'programmed cell death', a process in which the cell mediates its death via 
complex trigger mechanisms allows defective cells to be removed. One of the most 
common pathways consists of proteins known as caspases which are proteolytically 
cleaved in series to initiate apoptosis of the cell. Studies have found an increased 
presence of cleaved caspase 8 in UHRF 1 depleted cells and a similar increase of caspase 
3 residues in UHRF1 knockdown cells (Abbady et al., 2003; Tien et al., 2011). Thus cell 
cycle arrests due to depleted UHRF 1 expression results into cell death likely because of 
defective DNA methylation, increased DNA instability of cell cycle arrest. 
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UHRFl Regulates Cell Differentiation & Proliferation 
Cell differentiation is a process in which a cell becomes specialized for a definite 
function. Although active during embryogenesis, cell differentiation is constant in certain 
adult stem cell populations. For example, hematopoietic stem cell population, localized in 
the bone marrow, differentiates into erythrocytes, leukocytes, or platelets. Some believe 
that activation of zygotic genome and its lineage-specific progression during early 
development is not dependent on the DNA sequence, but on epigenetic modification 
(Mudbhary et al., 2011) . The expression of specific group of genes dictates the cell's 
lineage. Since UHRF1 affects epigenetic regulation, it also affects cell differentiation. 
UHRF1 levels are very low during the quiescent GO phase (such as adult hepatocytes) 
and are in increasingly expressed in proliferating or differentiating tissues (Hopfner et al., 
2002). Proliferative tissues like the testis, spleen, thymus, and lung tissues, where the 
cells are in the non-quiescent phases, strongly express Uhrfl as compared to non 
differentiating tissue with cells in GO phase such as in the brain, liver, or skeletal muscles 
(Fujimori et al., 1998). Attempts to generate Uhrfl null mice results in mid-gestational 
death of the embryo (Muto et al., 2002). In addition, Zebrafish with mutations in uhrfl 
fail to develop a liver bud and consequently do not survive the larval stage. In adult 
heterozygous uhrfl +l- zebrafish, liver proliferation following surgical resection known as 
partial hepatectomy is impaired when compared to the wild type adult fish (Sadler et al. , 
2007). Analysis of liver regeneration in these fish shows a defect in the cell cycle and 
enhanced apoptosis in the uhrfl +l- fish (Ukomadu and Sadler, unpublished). Further 
evidence of the role of UHRF1 in cell cycle control has been illustrated by the finding 
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that cyclinA-Cdk2 phosphorylates UHRF1 and that this phosphorylation event is 
essential for embryonic development of the liver (Chu et al., 2012). These studies are 
consistent with the hypothesis that UHRF1 plays a critical role in cell cycle and 
epigenetic regulation of genes. 
The role of UHRF1 in cell proliferation has been highlighted by analysis of 
tumors. Because UHRF1 binds to the promoters of tumor suppressor genes directly 
(Unoki et al. , 2008), and suppresses expression, there is an implication that it may play a 
role in cell proliferation and cell growth. The current thinking is that UHRF 1 inhibits the 
expression of tumor suppressor gene, which leads to an in-balance between proto-
oncogenes and tumor suppressor gene. This tilts the balance in favor of oncogene 
expression and leads to uncontrolled proliferation, a hallmark sign of tumorigenesis. 
High levels of UHRF1 are found in many cancer cells including prostate, bladder, liver, 
and breast cancers. For prostate cancer, more than 50% of samples have elevated 
UHRF1 levels and UHRF1 levels correlates with survival rates of post-prostectomy 
patients with tumors confined to prostate gland (Babbio et al. , 2012). UHRF1 knockdown 
in prostate cancer cell line (PC3), leads to an increase in tumor-suppressing genes which 
in tum resumes its role in maintaining DNA and histone methylation and acetylation 
(Babbio et al., 2012). 
Another modality through which UHRF 1 regulates cell proliferation is via 
ubiquitylation of key cellular proteins (Chu et al. , 2012). Proteins destined to be 
destroyed are tagged with a chain of ubiquitins propagated by E3 ubiquitin ligases. Due 
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to the universality of this function, RING domains from a variety of proteins have been 
found to interact and facilitate ubiquitylation (Jackson et al., 2000). The sequence of 
RING and PHD domains suggest a role as a ubiquitin E3 ligases (Jenkins et al., 2005). 
Further studies have confirmed the ubiquitylation of all core histones: H2A, H2B, H3 and 
H4 by the RING domain (Citterio et al., 2004). Cells with UHRFl RING mutant domains 
had decreased rate of proliferation, implicating its role in cell maintenance (Jenkins et al., 
2005). In sum, the available literature to date implicates UHRF 1 via direct and indirect 
mechanism as a key regulator of chromatin function, DNA repair damage and cell cycle 
progression. As a result, UHRFl is an ideal target for cancer chemotherapeutics. 
UHRFl Homologs 
By screening for factors that bind to similar nuclear proteins as UHRFl, additional 
proteins namely UHRF2, UHRF3, and UHRF4 have been discovered in mammals. These 
proteins have the same domains with some variation in their amino acid sequence and 
location (Bronner et al., 2007). Interestingly, in lower organisms such as zebrafish and 
xenopus laevis only uhrfl is present. This has raised the possibility that these additional 
homologs may have over-lapping functions and thus may replace UHRFl in settings of 
gene disruption. Among these homologs UHRF2 function is currently being deciphered. 
Recent data suggest that UHRFl and UHRF2 have non- overlapping roles despite a 
greater than 65% overall protein similarity with 60%-79% identical residues in the 
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a a 1 76 127 285 310 366 .m 586 724 763 793 
UHRFl TUdor SRA 
65% 63% I 60% I I I 76% 
UHRF2 
76 119 316 347 392 466 612 733 771 802 
Figure 2. Sequence Homology Between UHRFl & UHRF2 Domains. 
The organization and amino acids (aa) numbers that correspond to the domains ofUHRFl and UHRF2 
with the percentage of homologous domain sequence shared by the two genes. (Figure amended from 
Zhang eta!., 2011.) 
domains (Fig 2). However, questions remain as to whether UHRFI and UHRF2 are 
temporally and spatial separated in mammalian cells. 
UHRFl Knockdown Cell Lines Are Helpful In Assessing Protein Function 
A limitation of the studies of UHRFI is the fact that it has been difficult to generate 
adult animal models that lack UHRF 1. In zebrafish, retroviral mediated insertion that 
results in homozygous deletion of uhrfl is lethal during embryogenesis (Sadler et al. , 
2007). Although heterozygous animals can live to old age and have impaired liver 
regeneration following injury (Sadler et al. , 2007), they nonetheless are not devoid of 
uhrfl. As expected from zebrafish studies, given the essential role ofUHRFl , an attempt 
to generate a conventional knock out ofUhrfl in mouse resulted in embryonic lethality. 
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Specific Aims 
To circumvent the problem of creating conventional knockout models of 
UHRF 1 our laboratory has generated a conditional knockout of Uhrfl and part of my 
thesis work is to characterize this mouse. Studies on this mouse would lead to selective 
and tissue specific deletion of Uhrfl and allow the identification of roles of Uhrfl in 
normal cells. Carcinogenic studies can then be performed in Uhrfl containing and 
depleted cells and for the interrogation ofUHRF1 's role in cancer. 
A second aspect of my studies was to use a human inducible pluripotent stem cell 
line (hiPS) to examine the expression of UHRF 1 and UHRF2 from early development 
(from iPS to endoderm) to the generation of hepatocyte like cells. These studies set the 
stage for work that would lead to significant knowledge on how UHRF 1 and its homolog 
regulate cellular function. 
In this study: 
1. We generated Uhrfl knockdown models both in vitro and in vivo, 
providing the platform to conduct further studies on the function and 
relationships of UHRF 1. 
u. We evaluated the trend in expression levels of UHRFl and UHRF2 in 
hiPS cells as they differentiate into hepatocytes by measuring mRNA 
expression of UHRF 1 at developmental milestones. 
111. We study the effects of 5-Azacytidine on Uhrfl expression in 3T3 cell line 
(mouse fibroblasts) . 
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II. MATERIALS & METHODS 
Animals 
Animals were housed in compliance with the Institutional Animal Care and Use 
Committee (IACUC) at Brigham and Women's Hospital. Animal research was conducted 
in conformity with federal and USDA guidelines and in accordance with an IACUC 
approved protocol (Harvard Medical School #0413). Cg-Tg(Alb-cre )21 Mgn/J[B6] mice 
homozygous for Tg(Alb-cre)21Mgn, were purchased from Jackson Laboratories (Bar 
Harbor, ME). 
Isolation of Mouse Embryonic Fibroblasts (MEFs) 
The pregnant female was sacrificed between day 12.5 and 14.5 by cervical 
dislocation and the uterine horns were extracted. Each hom was rinsed in 70% (v/v) 
ethanol and placed into a petri dish containing PBS. The embryos were transferred to a 
tissue culture laminar flow hood where they placenta and surrounding membranes were 
separated. Brain and other dark red organs were removed and rinsed in fresh PBS and 
retained for genotyping. Minimal amount of fresh PBS was added to each embryo and 
tissue was minced with razor blade in a 1 OOmm tissue culture plate (BD Biosciences, 
Franlin Lakes, NJ) until it became pipettable. 2ml of Trypsin-EDT A 0.25% (Invitrogen, 
Carlsbad, CA) were added to each plate and the cell/tissue mixture was incubated at 3 7°C 
for 1 hour with gentle shaking. The cell-tissue suspension was centrifuged at 1500 rpm 
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for 5 min with 10ml of fresh 1x Dulbecco's Modification of Eagle's Media (DMEM) + 
GlutaMAX (Invitrogen, Carlsbad, CA). The cells were plated in a new tissue dish and 
placed in a cell culture incubator at 37°C. Once confluent (-48 hours), the cells were 
carried for 1-2 passages and then split into multiple plates before they were harvested or 
infected for subsequent experiments. 
Materials & Cell Culture 
All cell lines and MEFs were grown in 10 % (v/v) FBS (fetal bovine serum) and 
1% (v/v) penicillin/streptomycin antibiotics in DMEM. In knockdown experiments, cells 
were infected with adenovirus or empty vector tagged with Green Florescent Protein 
(GFP) epitope in equal amounts (Sml/1 05 cells). Cells were infected twice, at 24 hour 
intervals and harvested 48 hours after the initial infection. Multiple plates were infected 
and harvested to extract protein, DNA, and RNA simultaneously. For DNA 
hypomethylation assay, 5~-tM of 5-Azacytidine (MP Biochemicals, Solon, OH) was added 
to 3T3 cells when they were 50% confluent. The cells were harvested after 48 hours and 
genomic DNA was isolated. 
Conditional Knockdown of Uhrfl 
Conditional knockouts of Uhrfl were made through Cre-loxP system. UHRF1 has 
17 exons with ATG in the second exon and two zinc finger domains; one in exon 7 and 
another on the C-terminal of the protein. A loxp83 sequence was introduced 
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encompassing exons 6, 7, 8, 9, and 10 and a stop codon was introduced 4 amino acids 
downstream of aa322 (Fig. 3A). Mice that are homozygous for floxed Uhrfl alleles (F/F) 
and heterozygous (WT /F) are separated by genotyping. In flo xed mice, the loxp site is 




F/F FIF F/F WT/WT \YT/F F/F 
Figure 3. Conditional Knockout Mice were Generated with Cre-lox Technology. 
F/F WT/F 
(A) Loxp89 sites were introduced before exon 6 and after exon 10 to excise exons 6-10 of Uhrfl gene. 
Stop codon is introduced 4 aa upstream of exon 6. (B) Genotyping results shows bands at 437bp, 520bp, 
or both. If loxp89 site is present the LNL primers transcribes a 520bp segment as compared to a 437bp 
segment in WT mice due to the absence of loxp89 sites. Heterozygous mice will show both bands. 
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( exons 1-5 or exons 1 0-17) will be longer (520bp) as compared to wild type mice that 
lack loxp sites (437bp). Floxed mice can then be used to generate conditional Uhrfl 
knockout mice or knockdown Uhrfl expression in vitro. 
For the in vitro assay, UhrflFIF MEFs were infected with Cre recombinase 
adenovirus (Cell Biolabs, Inc., San Diego, CA). To generate enough virus, HEK293T 
(human embryonic kidney) cells were passaged 2-3 times and grown until the monolayer 
was 90% confluent before infecting them with the crude adenovirus stock. Recombinant 
adenoviruses lack the E1A and E1B genes, which are necessary to proteins that allow 
them to replicate. HEK293T cells provide the E1A and E1B proteins and allow 
recombinant adenoviruses to produce more virus particles. The cells were harvested when 
they displayed cytopathic effects (CPEs) such as cell rounding, swelling, and loss of cell-
cell contact (24-48 hours). Another set of HEK293T cells were used concurrently to 
generate empty vectors as controls. Adenovirus plasmid contains Cre recombinase gene 
and a GFP gene, both driven by separate promoters, while empty vectors contain only the 
GFP transgene. Infected HEF293T cells were centrifuged at 1500rpm for 5 minutes. The 
cells were passed through three freeze-thaw cycles between room temperature and liquid 
nitrogen and then centrifuged again. The supernatant containing the virus was purified 
using Virabind adenovirus purification kit (Cell Biolabs, Inc., San Diego, CA) according 
to manufacturer's protocol. The virus and empty vector were concentrated to 1013 
particles/mi. Purified virus and empty vector was added to MEFs in100mm plates at 
5ml/5x105 cells (~50% confluent). 5 sets of plates were infected with the virus and empty 
vectors and harvested 48 hours post-infection to maintain consistency between 
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experiments. Efficacy of infection can be seen through fluorescent imaging with the 
expression of GFP. 
For in vivo knockdown of Uhrfl, homozygous albumin-ere recombinant mice are 
mated with UhrflFIF mice. Heterozygous mice from resulting progeny will have Uhrfl 
( exon6-1 0) cleaved, making them Uhrfl knockouts. Since Cre homozygous ( Cre + /Cre +) 
and heterozygous (Cre+/UhrflF1F) show similar bands, western blot analysis were 
performed to confirm the genotype. 
Polymerase Chain Reaction (PCR) and Genotyping 
Genomic DNA was isolated from organs that were extracted during MEF isolation 
procedure using the protocol stated by DNeasy Blood & Tissue Kit (Qiagen, Valencia, 
CA). A PCR Screen for WT/F allele was run using 1~-tgl~-tL of LNL primers (Invitrogen, 
Carlsbad, CA). Primer sequence is included in Table 1. Each PCR reaction consisted of: 
2~-tL of genomic DNA, 1~-tL each of forward and reverse primers (1~-tgl~-tL ), 1~-tL of 
Dimethyl Sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MS), 5~-tl of ddH20 , and 1 0~-tl of 
HotStarTaq Plus Master Mix (Qiagen, Valencia, CA). Genomic DNA was amplified 
using SIOOO Thermal Cycler (Bio-Rad, Hercules, CA) with the following PCR 
conditions: 94°C for 1 min, 38 cycles at 94°C for 1 min, 62°C for 6 min, 72°C for 2 min, 
and finally 72°C for 10 min. 
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Screening for Cre + mice, each PCR reaction consisted of: 2flL of genomic DNA, 
0.5JlL each of forward and reverse Cre Transgene and positive control primers, 5Jll of 
ddHzO, and 10fll ofHotStarTaq Plus Master Mix. PCR conditions for DNA amplification 
were: 94°C for 3 min, 35 cycles at 94°C for 30 sec, 51.7 oc for I min, 72°C for 1 min, 
and finally 72°C for 1 min. 
The samples were run on a 1% Agarose Gel and analyzed with Gel Doc XR+ 
Molecular Imaging System (Bio-Rad, Hercules, CA) and Image J software (National 
Institutes of Health, Bethesda, MD). Homozygous WT samples showed a band at 437bp, 
homozygous flox samples showed a band at 520bp and heterozygous samples showed 
two bands at 437bp and 520bp (Fig. 3B). For knockdown experiments, Cre + mice 
presented a band at 1 OObp while positive controls showed a 324bp band. Primer 
sequences of Cre transgene and positive control used for PCR are listed in Table 1. 
RNA Extraction, eDNA Preparation, and PCR 
RNA was extracted using an RNeasy spin column kit (Qiagen, Valencia, CA) 
according to the manufacturer's protocol. RNA concentration of samples was measured 
with Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA). For experiments with 
human iPS cells, RNA samples of human induced pluripotent stem (hiPS) cells at dayO, 
day 5, day 10, day15, day 20, day 25, and adult human hepatocytes were provided by 
Robert Schwartz (Massachusetts Institute of Technology, MA). eDNA was synthesized 
from 0.5Jlg of total RNA using the protocols stated in Protoscript M-MuL V First Strand 
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eDNA synthesis Kit (New England Biolabs, Ipswich, MA ). For all other assays, the first 
strand eDNA was synthesized from 2)lg of total RNA using SuperScript III RT 
(Invitrogen, Carlsbad, CA) for RT (reverse transcription)-PCR. qPCR samples were 
prepared using LightCycler 480 SYBR Green reagent and detector system (Roche 
Applied Science, Indianapolis, IN) according to manufacturer's protocol. The samples 
were run in quadruplicates using CFX96 Real Time System (Bio-Rad, Hercules, CA) 
with the following parameters: 95°C for 3 min, 30 cycles at 95°C for 30 sec, 58°C for 30 
sec, 72°C for 30 sec, and finally 72°C for 2min. The fractional cycle number at which the 
fluorescence passes the fixed threshold (CT values) was used for quantification by using 
a comparative Ct method as described in the manual. Gene expressions were normalized 
to mycyclo as a reference. Statistical power of the difference between the two genes was 
calculated and plotted. Primer sequences for qPCR are shown in Table 1. 
DNA Isolation and Digestion 
DNA was extracted usmg a DNeasy spm column kit (Qiagen, Valencia, CA) 
according to the manufacturer's protocol. DNA concentration of samples was measured 
with Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA). 1 )lg of DNA was 
incubated with 2).11 of lOx Buffer (supplied with enzymes), water, and 1.5).11 of Hpaii or 
Mspi enzyme (New England Biolabs, Ipswich, MA) for 1 hour at 37°C. Controls were 
incubated with water in similar conditions. The samples were run on 1% Agarose Gel 
with Ethidium Bromide and analyzed with Gel Doc XR+ Molecular Imaging System 
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(Bio-Rad, Hercules; CA) and Image J software (National Institutes of Health, Bethesda, 
MD). 
Western Blot Analysis 
MEFs were harvested 48 hours post-infection and lysed with 2001-.d / lxl 07 cells of 
lysis buffer containing phosphatase inhibitor (phosphostop- Roche Applied Science, 
Indianapolis, IN) and protease inhibitor (Complete-Roche Applied Science, Indianapolis, 
IN) in order to inhibit protein degradation and dephosphorylation of samples. Some 
cancer cell line lysates were acquired from Dr. Baran Ersoy (Harvard Institutes of 
Medicine, MA). The lysates were spun down at 12000rpm for 5min at 4°C and the 
supernatant was extracted into a 1.5ml eppendorf tube to remove any cell debris. The 
pellet was stored at -80°C. 
To determine protein concentration, a serial dilution was conducted with lJlg/JlL 
Bovine Serum Albumin (BSA) (New England Biolabs, Ipswich, MA) in a 96 well plate 
(Fisher Scientific, Hampton, NH). Standards are used to have a reference curve from 
which to determine the concentration of the unknown samples. lJlL of protein samples 
were placed in individual wells and Protein Assay Dye Reagent Concentrate (Bio-Rad, 
Hercules, CA) containing dye, phosphoric acid, and methanol was added to each well. 
Controls and unknowns were measured in triplicates with a spectrophotometer set at 
595nm wavelength. The absorbance of light at 595nm, in each well was measured using 
VersaMax Microplate Reader (Molecular Devices, Sunnyvale, CA) and recorded in a 
Microsoft Excel spread sheet. From the data acquired, a curve was generated from the 
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controls and protein concentration of each sample was calculated usmg the linear 
equation of the curve. 
The lysates were thawed on ice and 30f..lg of protein was extracted. Water was 
added to equal the volume and 6x SDS loading buffer was added before the samples were 
boiled at 1 00°C for 5min. The samples were loaded on a 10% 10% Polyacrylamide gel 
with a protein marker (Fisher Scientific, Hampton, NH) and ran at 150V for 1 hour using 
Western blot apparatus (Bio-Rad, Hercules, CA). The gel was transferred on protran 
nitrocellulose transfer membrane (PerkinElmer, Waltham, MA) at 120 rnA for 2 hours 
using semi-dry blotting apparatus (Fisher Scientific, Hampton, NH). Upon removal from 
the transfer cell, the membranes were rinsed with ddH20 and then placed in Ponceau S 
(Acros Organics- Fisher Scientific, Hampton, NH) solution and placed on an agitator for 
5 minutes in order to reversibly stain and visualize the proteins that were transferred to 
the membrane. Membranes were then placed for 1 hour on a rocker in a blocking solution 
of 5% Milk in Phosphate Buffered Saline (PBST). PBST was made from 1 Ox PBS and 
1% Tween 20 (Sigma-Aldrich, St. Louis, MS) in ddH20. Conditions for primary 
antibodies varied but majority were incubated at the ratio of 1: 1000 in milk overnight at 
4°C. Membranes went through 3 washes of PBST, 5min each at room temperature before 
they were placed in respective secondary antibodies at 1 :2000 for 1 hour. List of primary 
antibodies is included in Table 2. Membranes again went through 3 washes lasting 5 min 
each in PBST and were in turn placed in Western Blotting Luminol Reagent (Santa Cruz 
Biotechnology, inc., Santa Cruz, CA) for 1-2 minutes before being placed between two 
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plastic transparencies and placed in a cassette and exposed onto a film (Kodak, 
Rochester, NY) in the dark room for optimum time periods and developed. 
Statistical Analysis 
Multiple samples of each group were tested in triplicates for qPCR analysis (except 
human hepatocyte sample). Results were expressed as means ± SEM. The difference 
between two mean values was analyzed by student's t-test and was considered as 
statistically significant in case ofP<0.05 and very significant for p<O.OOl. 
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III. RESULTS 
UHRFl Can Be Selectively Depleted In-Vivo and In-Vitro 
Cancer cell lines and primary tumors have reported high levels of UHRF 1 (Tien et 
al. , 2011), but their levels vary significantly across different cancers. In Figure 4A & B, 
western blot is used to show that expression of UHRF1 in various cancer cell lines (Fig. 
4A & B). This makes it difficult to understand the role of UHRF1 in cancer cells. For 
example, there is more than a 20 fold difference found between the UHRF 1 expression in 
PC3 (prostate adenocarcinoma) cells and T47D (ductal breast cancer) cells. To conduct 
studies on the role of UHRF1 in various cell cycle mechanisms, Cre recombinant 
adenovirus was used, with GFP marker gene, to create conditional Uhrfl knockdown in 
flox/flox MEF cell lines. 48 hours after infection of cells, most cells were GFP positive as 
assessed by fluorescent imagining (Fig. SA). Western blot analysis and qPCR analysis 
showed ~50% UHRF1 knockdown in protein expression (Fig. 5B) and ~70% in mRNA 
expression (Fig. 5C). The positive controls were cells infected with empty virus plasmids 
with GFP, to rule out effects ofGFP. 
Uhrfl knockout mice were acquired by mating albumin-ere mouse models with 
Uhrfi FIF mice. An important advantage of in vivo gene knockdown is that it allows us to 
study physiological effects of UHRF 1 such as tumor growth and immune response. 
Albumin-ere mice, similar to adenoviral vectors, express Cre recombinase transgene that 
is driven by a 2.34kb mouse albumin enhancer/promoter (The Jackson Laboratory). 
Since, the gene can only be transcribed in conjunction with albumin; it is expressed 
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Figure 4. UHRFl Expression in Human Cancer Cell Lines. 
(A) Western blot showing UHRFl (ICBP90) in human cancer cell lines. GAPDH was used as loading 
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Figure 5. In vitro Knockdown of Uhrfl in MEFs. 
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(A) Fluorescence Imaging of MEFs showed GFP positive cells for both empty vector and Cre 
recombinant adenovirus, suggesting efficient infection of cells. (B) Western blot confinned partial 
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Figure 6. Liver Specific UHRFl Knockout Mice were Generated by Mating Albumin-Cre 
Recombinase Mice with UhrflFI.F 
(A) Albumin-Cre +and Uhrfl F!F mice can be mated to generate Alb-Cre + -UhrflFIF mice in which exons 
6-10 of UHRFl are cleaved. (B) Western blot showing Uhrfl knockdown in liver tissue of Alb-Cre+-
Uhrfl FIF using Cre-/ UhrflFIF as positive control. 
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exclusively in liver hepatocytes. Cre + -UHRFJFIF mice produced by mating Cre +I+ and 
Uhrfl FIF mice express the Cre recombinase gene and loxp89 sites around Uhrfl exons 6-
10 (Fig. 6A). Cre protein recognizes the floxed sites and produces a truncated protein of 
325aa with N-terminal which is non-functional due to the lack of both zinc finger 
domains. Since the promoter is albumin driven, knockouts are limited to liver cells (Fig. 
6B) 
UHRFl & UHRF2 have Different Expression Levels in hiPS Cells 
Studies have measured Uhrfl and Uhrf2 levels in samples of embryonic stem cells 
and somatic cells, but the trends in the expression of the two proteins can be better 
understood when monitored in a cell lineage assay. To test this hypothesis, mRNA levels 
of both UHRF 1 and UHRF2 were measured at periodic milestones during the 
differentiation of hiPS cells to day 25, when they are fully differentiated into hepatocyte 
like cells. 
Induced Pluripotent Stem (iPS) cells, in contrast to ESC are derived from adult 
somatic cells by inducing the expression of same genes as in ESC. iPS cells can develop 
into the required cell lineage by the expression lineage specific genes. During 
development iPS cells differentiate into endoderm, and then into a hepatoblast, which can 
produce either an adult hepatocyte or can differentiate in a cholangiocyte (Fig 7 A). 
mRNA expression of UHRF 1 increases as hiPS cells differentiate into endodermal cells 
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Figure 7. Expression of UHRFl and UHRF2 in hiPS cells. 
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(A) Developmental milestone of hiPS cells as it differentiates into endoderm, hepatoblast, and 
hepatocyte. (B) Quantitative PCR comparing UHRFI and UHRF2 showed minimal correlation between 
their expression levels. (C) Fold change of UHRFI expression when compared to day 0 was moderate. 
(D) Fold change in UHRF2 expression was dramatic between day 0 and adult human hepatocytes. 
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Adult human hepatocyte samples were tested as positive controls to compare the 
expression levels of day 25 samples, by which hiPS cells would have been completely 
differentiated into hepatocytes. Only a 1.5 times fold change in UHRFl mRNA 
expression was noticed between day 0 and adult human hepatocyte samples (Fig. 7C). 
UHRF2 mRNA expression, on the other hand, was unchanged from day 0 to day 5 but 
there was a 5 fold increase in UHRF2 expression in fully differentiated adult hepatocyte 
(Fig. 7D). 
5-Azacytidine Treatment Increases Uhrfl Expression in Mouse Fibroblasts 
UHRFl has been known to affect DNA methylation by binding to hemi-methylated 
DNA and also through its interaction with DNMTl (Bostick et al., 2007). Abnormal 
methylation of promoter regions of regulatory genes such as tumor-suppressor genes can 
silence their expression leading to uncontrolled proliferation of the cell (Cheng et al., 
2003). Similarly, hypomethylation can cause an over-expression of genes causing 
cancers. Since Uhrfllevels in itself can cause tumorigenesis, it was essential to test the 
effects of hypomethylation on Uhrfl expression. 
5-Azacytidine is an analog of cytidine with nitrogen substituted for carbon-S in the 
pyrimidine ring (Cheng et al., 2003). The structural similarities of 5-Azacytidines make 
them a false substrate during DNA and RNA transcription, which then inhibits DNMTl 
from methylating the bases. This property makes them a potent chemotherapeutic agent 
(Kim et al., 2012). To confirm that the DNA is hemi-methylated upon being treated with 
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5-Azacytidine, the genomic DNA was harvested from the cells (Fig 8 A) and digestions 
were performed with methylation specific enzymes Hpaii and Mspl. With the exception 
of lane 13, where there is a loading error, an increased sensitivity to Hpaii digestion in 5-
Azacytidine treated samples was noticed when compared to untreated samples (Fig. 8A 
compare lanes 4-6 with 13-15). Then, the RNA extracted from the same set of cells were 
found to have an increase in Uhrfl mRNA levels when treated with 5-Azacytidine (Fig 8 
B). This increase in Uhrfl expression with 5-Azacytidine treatment suggests that Uhrfl 
itself is controlled by methylation and arrest in cell cycle progression was likely due to 
the accumulation of UHRF1 at DNA methylation sites. In a recently submitted 
manuscript from our lab, analysis of 104 hepatocellular cancers also confirmed that an 
increase in hypomethylation of Uhrfl promoter leads to increased Uhrfl levels 
(Ukomadu et al., unpublished observation). This observation that 5-Azacytidine increases 
Uhrfl suggests that overexpression in some cancer cells may be due to impaired DNA 
methylation or DNA repair mechanisms. 
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Figure 8. 5-Azacytidine Successfully Prevents Methylation of DNA in 3T3 Cells. 
(A) Methylation specific endonuclease Hpall recognized the restriction site when the second cytosine 
is methylated while its isoschizomer Mapl recognizes both methylated and unmethylated cytosine 
(except one sample treated with Hpall). (B) Quantitative PCR assay showed an increase in Uhrfl 
mRNA expression in 5-Azacytidine treated 3T3 cells. (C) Restriction site recognized by Hpall and 
Mspl. Hpall is methylation specific while Mspl is non-specific. 
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IV. DISCUSSION 
UHRF 1 has been shown to play a crucial role in cell cycle progression and 
differentiation. The crystal structure and amino acid sequence of each domain gives it a 
specific function making it important both as a checkpoint protein during DNA damage 
and a response mediator through protein ubiquitylation and caspase 8- dependent 
apoptosis of the cell. Cancer cells depleted of UHRF1 arrest in 0 2/M phase (Tien et al. , 
2011) and this confirms its involvement in maintaining genomic integrity. Surprisingly, 
overexpression of UHRF1 has also shown adverse effects on cell cycle, leading to 
uncontrolled growth and tumorigenesis. To gain understanding of a protein with such 
varied functions, it is important to compare cell cycle progression of normal cells with 
cells that express no UHRF 1 and cells that express more than normal levels of UHRF 1. 
Studies have shown that overexpression of UHRF 1 in many human cancer cells 
lines, but their levels of expression can greatly vary between different cancer lines. This 
study demonstrates the variance ofUHRF1 expression within cancer lines. T47D (ductal 
breast cancer) cells showed a twenty fold higher UHRF1 expression compared to DLD1 
(colon cancer) and PC3 (prostate cancer) cell lines (Fig 4). Such a wide difference in 
expression makes it difficult to link inconsistencies in cell cycle specifically to UHRF 1. 
In addition, studies have shown that in vivo knockdown of Uhrfl in mouse and zebrafish 
have proven to be lethal for embryonic development (Muto et al., 2002; Chu et al., 2012), 
making it impossible to gain insights into the mechanisms of Uhrf11 and establish a link 
between UHRF 1 expression levels and cell cycle regulation. 
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To overcome these problems, a knockout mouse of Uhrfl was generated by 
conditional knockout. Animals are grossly normal when compared to wild type mice and 
Uhrfl can be relatively knocked out in tissues specific manner by the introduction of Cre 
recombinase. As an example, this study shows two ways to generate Uhrfl knockdown. 
In vitro, Uhrfl knockdown was achieved through Cre recombinant adenovirus tagged 
with GFP. The infection with adenovirus and empty vector was confirmed with 
fluorescent microscopy. The western blot analysis showed a partial knockdown of Uhrfl 
in Cre treated protein lysates compared to the control. To quantitate the efficacy of 
infection, qPCR results confirmed a 60-70% knockdown of Uhrfl in cells. Since MEFs 
tend to stop growing by cell-cell contact and the plates were already 50% confluent when 
the virus was added, one possibility to explain this partial knockdown is that cells 
stopped growing once the primary monolayer was confluent. So the lysates contained 
uninfected cells present prior than adding the virus. Although the partial knockdown of 
Uhrfl was significant (p<0.05), complete knockdown can be achieved by adding the 
virus to plates with fewer cells and may lead to more dramatic results. 
Western blot analysis of in-vivo knockout mice models, generated by mating 
albumin-ere recombinant mice with Uhrfl FIF mice, showed a complete knockdown of 
Uhrfl in mouse liver samples, 48 hours after partial hepatectomy. Partial hepatectomy 
triggers the liver cells to enter the proliferative stage during which Uhrfl is upregulated 
as seen in Cre/ Uhrfl FIF models. These models can be used in subsequent experiments to 
compare cell cycle changes between Uhrfl knockout and normal cells. This is the most 
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convincing manner to attribute changes in cell cycle phases, arrest, check-proteins, and 
apoptosis, specifically to Uhrfl expression. 
Recently, there has been a considerable focus on UHRF1 homologs, due to their 
presence only in humans as compared to non-mammalian animals such as zebrafish in 
which only uhrfl has been identified (Zhang et al. , 2011). Studies have shown that 
UHRF2, although having similarities in domain sequences and functions such as binding 
to hemimethylated DNA and H3K9, is unable to rescue DNA methylation defects in 
Uhrfl knockout mice (Zhang et al., 2012). The present study confirms that UHRFl 
expression increases when the cells are in proliferative stage (day 0 and day 5) and its 
expression decreases in differentiated cells (day 15). On the contrary, UHRF2 levels are 
relatively unchanged during differentiating phase of hiPS cells but its expression 
increases by 6 fold in fully differentiated hepatocytes. Regardless, what is obvious is that 
UHRF 1 levels are low during differentiation and increase in fully differentiated 
mammalian cells. Thus it may be that UHRF2 serves a primary role in maintaining DNA 
methylation in differentiated cells. These samples can further be tested for expression 
levels of proteins markers, which changes at different developmental stages. This can 




Successful knockdown of Uhrfl opens possibilities for a wide range of 
experiments. The roles of UHRF 1 in DNA methylation, histone modification, cell cycle 
arrest, and apoptosis will be tested in Uhrfl knockout mice while at the same time 
monitoring whether UHRF2 is sufficient to rescue DNA repair and cell cycle 
progression. Moreover, domain specific deletions will give insights into where UHRF2 
acts in differentiated tissue and which domains are responsible for it. Uhrfl knockout 
models provide the platform to test the functions and reasons for the presence of other 
homologs in mammalian systems. hiPS samples will be tested for expression of marker 
proteins at each developmental stage to make sure that the cells can be considered 
functionally similar as during the differentiation of human embryonic stem cells. Protein 
lysates of hiPS cells can be used to see a difference in cell cycle checkpoint proteins and 
determine a plausible function and mechanism of action as to why there is a difference in 
UHRF 1 and UHRF2 levels in differentiated hepatocytes. 
The quality of the Uhrfl knockout mice allows us to address the exact roles of 
UHRF1 in response to injury in normal and cancer cells. Two lines of studies are 
envisioned: 1) In vitro , Uhrfl will be knocked out using adenovirus Cre-GFP and then 
compare response to DNA damage by irradiation for cells containing or deficient of 
Uhrf1. 2) Cancers can be induced in the livers of mice containing or deficient of Uhrfl , 
using a cancer causing agent- N-Nitrosodiethylamine and cancer models have been 
generated in our lab within a 8 month period. If Uhrfl is an oncogene then It is expected 
to see a delay in tumor generation in mice lacking Uhrfl . The role of Uhrfl in DNA 
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methylation progression in cancers can be ascertained by knocking out Uhrfl after tumor 
growth. This can be accomplished by mating our mice with mice in which Cre 
recombinase is driven by MX promoter. Cell disruption can then be accomplished by 
injecting polyinosine-polycytidylic acid. It can also be determined if hepatocellular 
cancers that lack Uhrfl are less aggressive compared to those containing it. 
Conclusions 
There is a need to develop Uhrfl knockout models to study its effects in cell 
cycle regulation. Uhrfl knockdown can be achieved through in vivo and in vitro assays. 
In addition, these models are a valuable resource to understand the role of other UHRF 1 
homologs, which are not present in non-mammalian animals. UHRFl and UHRF2 
expression, suggest that their functions in cell cycle progression do not overlap 
completely and to point out the exact targets and functions of UHRF2, it is necessary to 
study it in Uhrfl knockout models. This study provides the platform through which the 




















Table-t Primer Sequences 
Forward Reverse 







5'-GAAGGAACA TT AAA TGACTGCAAG-3' 5-CAA TACCAGTA TTCCTCTTCTGGGAC-3' 
5'-GGCCGATGACGAGC-3' 5'-TGTCTTTGGAACTTTGTCTGCAA-3' 








Santa Cruz Biotechnology 
Sigma-Aldrich 
Cell Signaling Technology 
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